Hologic announced today that it completed its $350 million acquisition of Gynesonics. Marlborough, Massachusetts–based Hologic announced an agreement to buy Gynesonics in October. Gynesonics develops minimally invasive medical device solutions for women’s health, including the Sonata system. Gynesonics designed Sonata for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids. That includes those […]
Hologic
FDA says do not use Hologic’s BioZorb marker implants following recall
The FDA is advising consumers and healthcare providers not to use BioZorb Markers and BioZorb LP Markers made by Hologic following a recent recall. Hologic issued a voluntary recall on October 24 for all unused BioZorb markers following reports of serious adverse events in patients who had the devices implanted in breast tissue. The company […]
Hologic to close Connecticut facility, lay off 86 employees
Hologic notified the state of Connecticut that it plans to cut 86 jobs at its Danbury, Connecticut facility. CTInsider first reported the layoffs yesterday, Oct. 21. The women’s health and diagnostics company sent a letter notifying Connecticut’s Labor Dept., dated Oct. 18, 2024. Layoffs at Hologic may raise eyebrows after CFO Karleen Oberton gave an […]
Hologic to acquire Gynesonics in $350M deal
Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million. Gynesonics develops and sells the Sonata System, a diagnostic intrauterine imaging and transcervical treatment system for symptomatic uterine fibroids. The company designed the system to combine real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in a minimally invasive procedure. […]
The top 10 women’s health stories of the year so far
It has been a blockbuster year for women’s health as the federal government and medtech place particular focus on the wellbeing of women. At the start of the year, President Joe Biden announced the federal government would focus its health initiatives on improving women’s health outcomes. Since then, his administration has announced two other federal […]
SEC charges medtech activist investor Icahn with failure to disclose securities for personal loan collateral
The Securities and Exchange Commission (SEC) today announced charges against activist investor Carl Icahn and his publicly traded company, Icahn Enterprises (IEP). The SEC alleged that Icahn failed to disclose the use of IEP securities for billion-dollar personal margin loans. To settle the charges, Icahn and IEP agreed to pay $500,000 and $1.5 million in […]
Hologic completes Endomagnetics acquisition
Hologic today announced it completed its $310 million acquisition of Endomagnetics. The acquisition was previously announced in April this year. It adds Endomag’s wireless breast surgery localization and lymphatic tracing solutions to Hologic’s breast surgery portfolio. It gives breast surgeons and radiologists an expanded range of options and enhanced user experience. “We are thrilled to […]
Hologic’s radiographic marker implant recall is serious due to complications with implanted devices
The FDA deemed a recall of the Hologic BioZorb radiographic marker Class I, the most serious kind. BioZorb — previously made by Focal Therapeutics, which Hologic bought out in 2018 — is an implantable radiographic marker used to mark soft tissue (such as breast tissue) for future medical procedures, such as radiation. It features two […]
Hologic to acquire Endomagnetics in $310M deal
Hologic is set to acquire breast surgical guidance company Endomagnetics for $310 million. Endomag develops and sells breast surgery localization and lymphatic tracing technology. It makes products like the Magseed marker for magnetic tissue localization before surgery. It also develops the Magtrace lymphatic tracing injectable for breast cancer staging and the Sentimag platform that supports […]
Hologic to shutter some facilities within diagnostics unit
Hologic plans to close certain international facilities amid product discontinuations and restructuring within its diagnostics business. The company outlined the changes — first reported by MedTech Dive — in its quarterly Form 10-Q filed with the SEC, dated Feb. 2, 2024. Hologic reported accelerated depreciation of $7.2 million and a lease asset impairment charge totaling […]
Hologic CFO: ‘Mass layoffs are a failure of leadership’
Hologic CFO Karleen Oberton had some tough words for ax-dropping executives following recent layoffs in the medtech industry and beyond. In an interview with the Wall Street Journal, Oberton and Hologic CEO Steve MacMillan — who together rode a wave of “COVID cash” from the company’s diagnostics business during the pandemic — discussed how they […]
